Senescent cells and metabolic disease. Senescence-associated secretory phenotype SASP. Senescent cells promote insulin resistance, liver steatosis, mu
Senescent cells and metabolic disease. Senescence-associated secretory phenotype SASP. Senescent cells promote insulin resistance, liver steatosis, muscle atrophy and Sarcopenia, hyperinsulinemia in pancreas, and atherosclerosis. Aging process and Chronic Inflammation. Vector diagram
Size: 5000px × 4888px
Photo credit: © Tetiana Zhabska / Alamy / Afripics
License: Royalty Free
Model Released: No
Keywords: adipose, age-related, aging, anatomy, apoptosis, atherosclerosis, atrophy, cancer, cell, cellular, chromosome, chronic, conditions, damage, death, destruction, diabetes, diagnosis, diagram, diet, digestion, disease, disorders, dna, dysfunction, fat, genetic, genome, hyperinsulinemia, illness, immune, infection, inflammation, insulin, liver, medical, metabolic, metabolism, muscle, necrosis, obese, obesity, oncology, overweight, oxidative, pancreas, pathology, phagocytosis, phenotype, process, rejuvenation, research, resistance, sarcopenia, sasp, science, secretory, senescence, senescence-, senescent, senolytics, steatosis, stress, structure, syndrome, telomere, tissue, treatment, tumor, unhealthy, vector, vectors, weight
